Related Experiment Video
Updated: Jan 1, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Nitric oxide and tumor metabolic reprogramming.
Laura M López-Sánchez1, Enrique Aranda2, Antonio Rodríguez-Ariza2
1Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Av. Menéndez Pidal s/n, E14004 Córdoba, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Av. Monforte de Lemos, 3-5, E 28029 Madrid, Spain.
Nitric oxide (NO) reprograms cancer cell metabolism, influencing nutrient use and mitochondrial function. This metabolic rewiring aids tumor growth, invasion, and immune evasion, with protein S-nitrosylation as a key mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Nitric oxide (NO) plays a complex role in tumor progression.
- Mechanisms linking NO to tumorigenesis, particularly metabolic reprogramming, require further elucidation.
Purpose of the Study:
- To review recent advances in understanding NO's role in cancer metabolic reprogramming.
- To highlight how NO influences cancer cell metabolism and the tumor microenvironment.
Main Methods:
- Literature review of recent research on NO and cancer metabolism.
- Discussion of NO's impact on glucose/glutamine utilization, mitochondrial function, and S-nitrosylation.
Main Results:
- NO influences glucose and glutamine metabolism in tumor cells.
- NO regulates mitochondrial function and dynamics, supporting cancer proliferation.
- NO-mediated metabolic changes affect the tumor microenvironment, promoting invasion and immune escape.
Conclusions:
- Metabolic reprogramming is a critical aspect of NO's multifaceted role in cancer.
- Protein S-nitrosylation is a central mechanism for NO-induced metabolic alterations.
- Further research into S-nitrosylation/denitrosylation is crucial for understanding NO's impact on cancer metabolism and the tumor microenvironment.
More Related Videos
08:32Application of Genetically Encoded Fluorescent Nitric Oxide (NO•) Probes, the geNOps, for Real-time Imaging of NO• Signals in Single Cells
Published on: March 16, 2017
07:07Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Related Concept Videos
Nitric Oxide Signaling Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...